ArticleAnnals of medicine2026
Geographic disparities and health inequality evolution in the disease burden of tracheal, bronchus, and lung cancer in Asia: a 33-year longitudinal analysis and future projections.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phytochemicals from Agro-Industrial By-Products for Breast Cancer Prevention and Therapy: Molecular Mechanisms and Circular Bioeconomy Perspective.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study examined geographic patterns, temporal trends, and determinants of tracheal, bronchus, and lung (TBL) cancer burden in Asia (1990-2023), evaluated disparities in health outcomes, and developed projections for targeted prevention initiatives.
methodsData were obtained from the Global Burden of Disease Study 2023. We estimated age-standardized rates (ASPR, ASIR, ASMR, ASDR). Joinpoint regression assessed temporal trends; age-period-cohort and Das Gupta analyses identified underlying mechanisms and drivers. Data envelopment analysis (DEA) evaluated efficiency relative to the Human Development Index (HDI). Health inequalities were measured with the slope index of inequality (SII) and concentration index (CI). Bayesian age-period-cohort (BAPC) modeling projected trends to 2038.
resultsAsian populations experienced 2.05 million prevalent cases, 1.40 million incident cases, 1.26 million fatalities, and 29.45 million DALYs in 2023. East Asia had the highest burden. From 1990 to 2023, ASPR increased, while ASMR and ASDR declined. Males and older adults carried disproportionately higher burdens. Decomposition analysis revealed that epidemiological changes and population growth were the major contributors. Inequality worsened, with SII rising from 275.8 to 311.6 and CI consistently negative, indicating concentration in low-HDI regions. Projections suggested further increases in ASPR (+28.7%) and ASIR (+21.6%) by 2038.
conclusionThe TBL cancer burden in Asia is rising, with marked regional, gender, age disparities and deteriorating health equity. East Asia is most affected. Targeted strategies, including enhanced early screening in high-burden areas and improved healthcare accessibility in low-HDI regions, are essential to reduce the disease burden and promote equity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.